RECRUITING

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows: 1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use); 2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits; 3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

Official Title

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Quick Facts

Study Start:2023-02-21
Study Completion:2028-12-14
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06121661

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult (≥18 yrs) Emergency Department (ED) patient
  2. * Triaged to the "Acute" area of the ED. (The "Acute" area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse).
  3. * Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation).
  1. * Prisoners
  2. * Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound
  3. * Patients wearing an "EFIC Opt-Out" bracelet
  4. * Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR \[lawfully authorized representative\] of the patient).

Contacts and Locations

Study Contact

Iain Kehoe
CONTACT
6177262241
ikehoe@mgh.harvard.edu

Principal Investigator

Andrew Reisner, MD
PRINCIPAL_INVESTIGATOR
Mass. General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02460
United States

Collaborators and Investigators

Sponsor: Andrew Tomas Reisner

  • Andrew Reisner, MD, PRINCIPAL_INVESTIGATOR, Mass. General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-21
Study Completion Date2028-12-14

Study Record Updates

Study Start Date2023-02-21
Study Completion Date2028-12-14

Terms related to this study

Additional Relevant MeSH Terms

  • Wounds and Injuries